keyword
https://read.qxmd.com/read/38349785/mass-spectrometry-based-profiling-of-histone-post-translational-modifications-in-uveal-melanoma-tissues-human-melanocytes-and-uveal-melanoma-cell-lines-a-pilot-study
#21
JOURNAL ARTICLE
Martina C Herwig-Carl, Amit Sharma, Verena Tischler, Natalie Pelusi, Karin U Loeffler, Frank G Holz, Michael Zeschnigk, Solange Landreville, Claudia Auw-Haedrich, Roberta Noberini, Tiziana Bonaldi
PURPOSE: Epigenetic alterations in uveal melanoma (UM) are still neither well characterized, nor understood. In this pilot study, we sought to provide a deeper insight into the possible role of epigenetic alterations in the pathogenesis of UM and their potential prognostic relevance. To this aim, we comprehensively profiled histone post-translational modifications (PTMs), which represent epigenetic features regulating chromatin accessibility and gene transcription, in UM formalin-fixed paraffin-embedded (FFPE) tissues, control tissues, UM cell lines, and healthy melanocytes...
February 1, 2024: Investigative Ophthalmology & Visual Science
https://read.qxmd.com/read/38346434/melanoma-arising-beneath-the-lateral-rectus-muscle-in-a-teenager-with-ocular-melanocytosis-possible-origin-from-intrascleral-melanocytes
#22
JOURNAL ARTICLE
Carolina A Chiou, Lisa Y Lin, Anna M Stagner, Nahyoung Grace Lee
Ocular melanocytosis is a well-established risk factor for choroidal melanomas but, despite its reported associations in the literature, it is infrequently discussed in relation to orbital melanomas. The authors describe a teenage patient with ocular melanocytosis who presented with an asymptomatic ipsilateral right orbital mass associated with the lateral rectus muscle. An exploratory orbitotomy revealed a lesion lightly adherent to the underlying sclera. Histopathology demonstrated a markedly atypical epithelioid melanocytic proliferation, bound by a thin rim of superficial sclera, implying an origin from intrascleral melanocytes, likely within an emissary canal...
February 9, 2024: Ophthalmic Plastic and Reconstructive Surgery
https://read.qxmd.com/read/38321238/pediatric-orbital-lesions-ocular-pathologies
#23
JOURNAL ARTICLE
Samantha K Gerrie, Heena Rajani, Helen M Branson, Christopher J Lyons, Eman Marie, Cassidy S Frayn, Emily C M Hughes, Oscar M Navarro
Orbital pathologies can be broadly classified as ocular, extra-ocular soft-tissue (non-neoplastic and neoplastic), osseous, and traumatic. In part 1 of this orbital series, the authors will discuss the differential diagnosis and key imaging features of pediatric ocular pathologies. These include congenital and developmental lesions (microphthalmos, anophthalmos, persistent fetal vasculature, coloboma, morning glory disc anomaly, retinopathy of prematurity, Coats disease), optic disc drusen, infective and inflammatory lesions (uveitis, toxocariasis, toxoplasmosis), and ocular neoplasms (retinoblastoma, retinal hamartoma, choroidal melanoma, choroidal nevus)...
February 7, 2024: Pediatric Radiology
https://read.qxmd.com/read/38301860/malignancies-with-a-tendency-to-metastasize-to-the-eyelid-or-ocular-structures
#24
JOURNAL ARTICLE
Elnara Muradova, Ashley M Hine, Madina Falcone, Jane M Grant Kels, Gillian Weston
Metastatic tumors to the eye and eyelid are generally seen in patients with disseminated metastases in the setting of advanced disease. Occasionally, they can present as the first sign of occult malignancy. The choroid is the most common site of intraocular metastases secondary to its dense vascular supply. Similar to the eye, metastatic tumors to the eyelid can present with variety of clinical findings and are most often seen in patients with known history of cancer. The most common skin malignancy that can spread to ocular structures is cutaneous melanoma, whereas the most common non-cutaneous malignancy is breast cancer followed by lung cancer...
January 30, 2024: Clinics in Dermatology
https://read.qxmd.com/read/38275828/management-of-uveal-melanoma-updated-cancer-care-alberta-clinical-practice-guideline
#25
REVIEW
Ezekiel Weis, Brae Surgeoner, Thomas G Salopek, Tina Cheng, Martin Hyrcza, Xanthoula Kostaras, Matthew Larocque, Greg McKinnon, John McWhae, Geetha Menon, Jose Monzon, Albert D Murtha, John Walker, Claire Temple-Oberle
OBJECTIVE: The purpose of this guideline update is to reassess and update recommendations in the prior guideline from 2016 on the appropriate management of patients with uveal melanoma. METHODS: In 2021, a multidisciplinary working group from the Provincial Cutaneous Tumour Team, Cancer Care Alberta, Alberta Health Services was convened to update the guideline. A comprehensive review of new research evidence in PubMed as well as new clinical practice guidelines from prominent oncology groups informed the update...
December 20, 2023: Current Oncology
https://read.qxmd.com/read/38273698/disinsert-retract-and-rotate-technique-of-plaque-brachytherapy
#26
JOURNAL ARTICLE
Neiwete Lomi, Bhavna Chawla, Deepsekhar Das
BACKGROUND: Plaque brachytherapy is commonly used in the management of choroidal melanomas. The surgical steps usually involve creating a conjunctival peritomy, fixing the recti muscles, with or without disinserting them based on the location of the lesion, and placing the plaque. The inferior oblique muscle is attached close to the macula, and in cases of perimacular or peripapillary lesions, the muscle needs to be sacrificed. PURPOSE: The authors here demonstrate a novel technique of placing radioactive plaque without disinserting the inferior oblique muscle in cases of perimacular or peripapillary choroidal melanomas...
February 1, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38264011/bilateral-vitiligo-like-depigmentation-of-choroid-and-retinal-pigment-epithelium-associated-with-ipilimumab-nivolumab-therapy-for-metastatic-cutaneous-melanoma
#27
Caroline C Cotton, Anirudha S Chandrabhatla, Mackenzie L Higgins, Yevgeniy Shildkrot
INTRODUCTION: Ipilimumab and nivolumab are checkpoint inhibitors that are known to cause a multitude of inflammatory ocular adverse events. Here we report a patient with poliosis and symptomatic depigmentation of the choroid and retinal pigment epithelium (RPE) associated with checkpoint inhibitor therapy for cutaneous melanoma. CASE PRESENTATION: The patient presented with floaters in both eyes and concerns for intraocular metastases of metastatic cutaneous melanoma after 1 month of therapy with ipilimumab and nivolumab...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38254884/quantitative-biomarkers-derived-from-a-novel-contrast-free-ultrasound-high-definition-microvessel-imaging-for-differentiating-choroidal-tumors
#28
JOURNAL ARTICLE
Shaheeda A Adusei, Soroosh Sabeti, Nicholas B Larson, Lauren A Dalvin, Mostafa Fatemi, Azra Alizad
Angiogenesis has an essential role in the de novo evolution of choroidal melanoma as well as choroidal nevus transformation into melanoma. Differentiating early-stage melanoma from nevus is of high clinical importance; thus, imaging techniques that provide objective information regarding tumor microvasculature structures could aid accurate early detection. Herein, we investigated the feasibility of quantitative high-definition microvessel imaging (qHDMI) for differentiation of choroidal tumors in humans. This new ultrasound-based technique encompasses a series of morphological filtering and vessel enhancement techniques, enabling the visualization of tumor microvessels as small as 150 microns and extracting vessel morphological features as new tumor biomarkers...
January 17, 2024: Cancers
https://read.qxmd.com/read/38230400/quantifying-the-effect-of-eccentric-ruthenium-plaque-placement-on-tumor-volume-dose
#29
JOURNAL ARTICLE
Jeremy P M Flanagan, William H F Udovenya, Melvin A Astrahan, Daniel McKay, Claire Phillips, John D McKenzie, Roderick O'Day, Lotte S Fog
PURPOSE: Ruthenium-106 brachytherapy is a common treatment for small to medium-sized uveal melanomas. In certain clinical contexts, plaques may be placed eccentrically to tumor center. The effect of plaque decentration, a common radiation dose measurement in radiotherapy: D98% , the percentage of the tumor volume receiving at least 98% of the prescribed dose (a commonly used term in radiation oncology), is unknown. We investigated this using two commonly used plaques (CCA and CCB; Eckert & Ziegler, BEBIG GmbH) in silico ...
December 2023: Journal of Contemporary Brachytherapy
https://read.qxmd.com/read/38223774/gene-expression-profile-class-change-in-a-case-of-aggressive-recurrent-melanoma
#30
Jennifer Aye, Aaron Gold, Belinda Rodriguez, Timothy Murray
Purpose: To report a novel case of a recurrent melanoma that had a change in its genetic expression profile (GEP) class over a 2-year period. Methods: This retrospective case study evaluated a patient with a recurrent uveal melanoma that changed classes from 1A to 1B. Results : A large melanoma was first treated with brachytherapy, and during that time genetic testing revealed a class 1A tumor. Two years later the tumor was noted to be enlarging, and the patient elected for enucleation. Subsequent GEP showed a class 1B tumor...
2024: Journal of Vitreoretinal Diseases
https://read.qxmd.com/read/38201546/cep-1347-dually-targets-mdm4-and-pkc-to-activate-p53-and-inhibit-the-growth-of-uveal-melanoma-cells
#31
JOURNAL ARTICLE
Keita Togashi, Shuhei Suzuki, Yuta Mitobe, Yurika Nakagawa-Saito, Asuka Sugai, Senri Takenouchi, Masahiko Sugimoto, Chifumi Kitanaka, Masashi Okada
Uveal melanoma (UM) is among the most common primary intraocular neoplasms in adults, with limited therapeutic options for advanced/metastatic disease. Since UM is characterized by infrequent p53 mutation coupled with the overexpression of MDM4, a major negative regulator of p53, we aimed to investigate in this study the effects on UM cells of CEP-1347, a novel MDM4 inhibitor with a known safety profile in humans. We also examined the impact of CEP-1347 on the protein kinase C (PKC) pathway, known to play a pivotal role in UM cell growth...
December 25, 2023: Cancers
https://read.qxmd.com/read/38201471/congenital-tumors-magnetic-resonance-imaging-findings-with-focus-on-rare-tumors
#32
JOURNAL ARTICLE
Piotr Kwasniewicz, Julia Wieczorek-Pastusiak, Anna Romaniuk-Doroszewska, Monika Bekiesinska-Figatowska
Congenital tumors are rare and, owing to this rarity, there is limited information on many of them. A total of 839 fetal and postnatal MRI studies performed in the first 3 months of life were retrospectively reviewed. They were performed with the use of 1.5 T scanners. Seventy-six tumors were diagnosed based on fetal MRI between 20 and 37 gestational weeks, and 27 were found after birth, from 1 day of age to 3 months of life. Teratomas were the most common tumors in our dataset, mainly in the sacrococcygeal region (SCT), followed by cardiac rhabdomyomas and subependymal giant cell astrocytomas (SEGA) associated with TSC, and neuroblastomas...
December 20, 2023: Cancers
https://read.qxmd.com/read/38196619/predicting-malignant-transformation-of-choroidal-nevi-using-machine-learning
#33
Sabrina P Iddir, Jacob Love, Jiechao Simon Ma, John M Bryan, Sanjay Ganesh, Michael J Heiferman, Darvin Yi
Objective This study aims to assess a machine learning (ML) algorithm using multimodal imaging to accurately identify risk factors for uveal melanoma (UM) and aid in the diagnosis of melanocytic choroidal tumors. Subjects and Methods This study included 223 eyes from 221 patients with melanocytic choroidal lesions seen at the eye clinic of the University of Illinois at Chicago between 01/2010 and 07/2022. An ML algorithm was developed and trained on ultra-widefield fundus imaging and B-scan ultrasonography to detect risk factors of malignant transformation of choroidal lesions into UM...
December 21, 2023: Research Square
https://read.qxmd.com/read/38179149/clinical-experience-of-stereotactic-radiosurgery-at-a-linear-accelerator-for-intraocular-melanoma-combined-with-iridociliary-tumor-resection-a-case-report
#34
Jela Valaskova, Martin Chorvat, Jozef Grezdo, Miron Sramka, Robert Furda, Pavol Vesely, Ivajlo Popov, Darina Lyskova, Alena Furdova
INTRODUCTION: The treatment of iridociliary and choroidal melanoma relies on the patient's systemic health, tumor size, location, related features, state of the opposing eye, and personal preferences. The two categories are radiation and surgical techniques. Transpupillary thermotherapy, plaque radiotherapy, charged particle irradiation, local resection, enucleation, orbital exenteration, and experimental nanoparticle therapy are all options for treating choroidal melanoma. CASE PRESENTATION: The method that entails creating a partial thickness circular, rectangular, or polyhedral scleral flap in the region covering the tumor after removing a portion of the extraocular muscles is the most popular method for local excision in choroidal or choroidal-ciliary body cancers...
2024: Case Reports in Ophthalmology
https://read.qxmd.com/read/38168658/intraocular-schwannoma-case-series-of-28-patients-and-literature-review
#35
JOURNAL ARTICLE
Li Dong, Xiao-Lin Xu, He-Yan Li, Qiong Yang, Rui-Heng Zhang, Wen-Bin Wei, Yue-Ming Liu
PURPOSE: Intraocular schwannoma is a rare tumour, which is often misdiagnosed. We presented the demographics and clinical characteristics of patients with intraocular schwannoma. METHODS: Retrospective case series were collected between May 2005 and July 2021 in Beijing Tongren Hospital. RESULTS: A total of 28 patients were diagnosed with intraocular schwannoma on histopathological examination of surgical specimen. The median age was 39 years (range: 12-64)...
January 2, 2024: Eye
https://read.qxmd.com/read/38131548/iodine-125-brachytherapy-for-choroidal-melanoma-by-using-ocuprosta-seeds-with-indigenous-non-collimated-plaques-our-initial-experience
#36
JOURNAL ARTICLE
Subina Narang, Awadesh K Pandey, Gurbir Kaur, Mannat Giran, Sanjay K Saxena, Sandeep Moudgil, Dinesh K Walia, Uma Handa, Vijay K Meena, Ravinder Kaur, Melvin Astrahan
PURPOSE: Brachytherapy is the gold-standard treatment for choroidal melanoma. This study evaluated iodine-125 brachytherapy by using Ocuprosta seeds with indigenous non-collimated plaques in Asian patients. METHODS: Retrospective single-center study in a tertiary care hospital of 12 eyes with choroidal melanoma in 12 Asian patients who underwent brachytherapy with Ocuprosta seeds fixed on non-collimated plaques and had a follow-up of at least 32 months (mean: 42...
January 1, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38115619/tebentafusp-as-a-promising-drug-for-the-treatment-of-uveal-melanoma
#37
JOURNAL ARTICLE
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Srijit Das, Abdullah Al Lawati
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes...
December 19, 2023: Current Drug Targets
https://read.qxmd.com/read/38113278/choroidal-amelanotic-mass-with-vermiform-margins-vision-loss-and-extreme-fatigue
#38
JOURNAL ARTICLE
Eleni K Konstantinou, Kevin R Card, Carol L Shields
PURPOSE: To describe a case of a previously healthy middle-aged male with an atypical choroidal mass and fatigue. METHODS: Case report. RESULTS: A 56-year-old Caucasian male presented with decreased vision in the right eye (OD) and a choroidal amelanotic mass OD with subretinal fluid. He received bevacizumab (1.25 mg/0.05 mL) injections by multiple providers without improvement in vision and with tumor progression. Visual acuity was 20/400 OD and 20/25 left eye (OS)...
November 22, 2023: Retinal Cases & Brief Reports
https://read.qxmd.com/read/38111469/focal-reactive-nodular-gliosis-an-extremely-rare-retinal-astrocytic-tumor
#39
Saúl Villoria-Díaz, María Antonia Saornil-Álvarez, Ciro García-Álvarez, Elena García-Lagarto, Irene Bermúdez-Castellanos
Focal reactive nodular gliosis (FRNG) is an extremely rare benign retinal reactive astrocytic tumor that results from the proliferation of well-differentiated glial cells secondary to a variety of retinal conditions. We describe a case of this tumor in a 64-year-old male in association with a chorioretinal scar he has had since childhood. The symptom was sudden painful vision loss. In the clinical examination, iris rubeosis, posterior synechiae, cataract, vitreous haze and a suspected fundus mass were showed...
2023: GMS Ophthalmology Cases
https://read.qxmd.com/read/38110833/tuberculosis-reactivation-demonstrated-by-choroiditis-and-inflammatory-choroidal-neovascular-membrane-in-a-patient-treated-with-immune-checkpoint-inhibitors-for-malignant-mucosal-melanoma
#40
JOURNAL ARTICLE
Melissa L Murphy, Duncan Rogers
PURPOSE: To describe a complex case of ocular tuberculosis reactivation with anterior uveitis, choroiditis and inflammatory choroidal neovascular membrane (CNVM) following immune checkpoint inhibitor (ICPI) treatment of malignant mucosal melanoma. METHODS: A retrospective collection of medical history, clinical findings and multimodal imaging with literature review of the topic was conducted. RESULTS: A 52-year-old Romanian female developed reduced vision and photophobia after three cycles of ICPI therapy comprised of ipilimumab and nivolumab...
December 18, 2023: Journal of Ophthalmic Inflammation and Infection
keyword
keyword
17963
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.